| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/14/1997 | EP0772688A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
| 05/14/1997 | EP0772687A2 Transgenic cereal plants |
| 05/14/1997 | EP0772686A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 05/14/1997 | EP0772685A1 Heat-stable prolylendopeptidase |
| 05/14/1997 | EP0772684A2 NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS $g(a)-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
| 05/14/1997 | EP0772683A1 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 05/14/1997 | EP0772682A1 Modification of starch content in plants |
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772680A1 A polynucleotide herpes virus vaccine |
| 05/14/1997 | EP0772679A1 Schistosoma protein and uses thereof |
| 05/14/1997 | EP0772678A1 Modulation of drug radiation resistant genes |
| 05/14/1997 | EP0772634A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
| 05/14/1997 | EP0772631A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 05/14/1997 | EP0772627A1 Production of biologically active recombinant neurotrophic protein |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772625A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 05/14/1997 | EP0772624A1 Interleukin-15 |
| 05/14/1997 | EP0772622A1 5'-dithio-modified oligonucleotides |
| 05/14/1997 | EP0772621A2 Oligonucleotides with anti-mdr-1 gene activity |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772456A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772454A1 Antisense oligonucleotides against hepatitis b viral replication |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0772404A1 Production of collagen in the milk of transgenic mammals |
| 05/14/1997 | EP0772399A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0668927B1 Analysis of dna |
| 05/14/1997 | EP0615453B1 Anti-cancer immunotherapeutic vector constructs |
| 05/14/1997 | EP0495131B1 Agent for preventing and treating hepatitis |
| 05/14/1997 | EP0441947B1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/13/1997 | US5629470 Mono and dicotyledon plants are genetic engeneered with bacterio-opsin gene |
| 05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
| 05/13/1997 | US5629414 Dna molecule coding for surface antigen of toxoplama gondii, vaccines |
| 05/13/1997 | US5629413 Oligonucleotides with activity against human immunodeficiency virus |
| 05/13/1997 | US5629407 DNA encoding an 18 KD CDK6 inhibiting protein and antibodies thereto |
| 05/13/1997 | US5629406 Amino acid derivatives |
| 05/13/1997 | US5629205 Promoters for gene expression |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629203 Genetic engineering |
| 05/13/1997 | US5629196 DNA encoding peptide hormone that inhibits digestion in insects |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629192 ETS1 gene: a human tumor suppressor gene |
| 05/13/1997 | US5629189 DNA encoding human cytoplasmic Cu/Zn superoxide dismutase |
| 05/13/1997 | US5629184 To cell cytoplasm, antisense therapy |
| 05/13/1997 | US5629183 Plant transformation by gene transfer into pollen |
| 05/13/1997 | US5629182 Obtained by cloning of chromosomal or plasmid dna of resistant bacterial strain |
| 05/13/1997 | US5629181 Synthesis of catechol from biomass-derived carbon sources |
| 05/13/1997 | US5629179 Method and kit for making CDNA library |
| 05/13/1997 | US5629177 Method for the enzymatic synthesis of oligonucleotides using thermostable 3'-phosphatase |
| 05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
| 05/13/1997 | US5629175 Molecular farming |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629172 Ubiquitin molecule is cleavage site |
| 05/13/1997 | US5629171 Recombinant bioprocess for the preparation of 7-amino cephalosporanic acid (7-ACA) |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5629161 Use of human papillomavirus gene derived peptides for diagnosis |
| 05/13/1997 | US5629160 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 05/13/1997 | US5629159 Immortalization and disimmortalization of cells |
| 05/13/1997 | US5629157 Double receptor polynucleotide assay method |
| 05/13/1997 | US5629156 Multiple capture probe sandwich assays |
| 05/13/1997 | US5629155 High-affinity oligonucleotide ligands to immunoglobulin E (IgE) |
| 05/13/1997 | US5629154 Telomerase activity assays |
| 05/13/1997 | US5629153 Diagnosis |
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/13/1997 | US5628994 Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom |
| 05/13/1997 | US5628781 Having a specified surface porosity and permeability |
| 05/09/1997 | WO1997016728A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
| 05/09/1997 | WO1997016568A1 DETECTION OF HUMAN α-THALASSEMIA MUTATIONS AND THEIR USE AS PREDICTORS OF BLOOD-RELATED DISORDERS |
| 05/09/1997 | WO1997016567A1 Double-stranded conformational polymorphism analysis |
| 05/09/1997 | WO1997016566A1 Sequence modification of oligonucleotide primers to manipulate non-templated nucleotide addition |
| 05/09/1997 | WO1997016564A1 Improved is6110 based molecular detection of mycobacterium tuberculosis |
| 05/09/1997 | WO1997016559A1 Plants with reduced glucosinolate content |
| 05/09/1997 | WO1997016558A1 Positive selection vector for bacillus sp. |
| 05/09/1997 | WO1997016556A1 Rationally designed polysaccharide lyases derived from heparinase i |
| 05/09/1997 | WO1997016555A1 Aspergillus niger beta-galactosidase gene |
| 05/09/1997 | WO1997016554A1 Modified plants and plant products |
| 05/09/1997 | WO1997016553A1 MUTANT MONO-OXYGENASE CYTOCHROME P450cam |
| 05/09/1997 | WO1997016552A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | WO1997016551A1 Human hepatitis b virus dna |
| 05/09/1997 | WO1997016550A1 Polypeptide fragments derived from the obese gene product |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016547A1 ADENOVIRUS-ANTISENSE K-ras EXPRESSION VECTORS AND THEIR APPLICATION IN CANCER THERAPY |
| 05/09/1997 | WO1997016546A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | WO1997016540A1 Chitin synthase 1 |
| 05/09/1997 | WO1997016539A1 Recombinant sendai virus |
| 05/09/1997 | WO1997016538A1 (-)-strand rna virus vector having autonomously replicating activity |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016533A1 Mammalian artificial chromosomes and methods of using same |
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016530A1 New e.coli mutant with suppressed organic acid production |
| 05/09/1997 | WO1997016528A1 A mutant e. coli strain with increased succinic acid production |